Intellectual Property Licensing Opportunities, Antibody Humanization, Drug Discovery Initiatives and Facilitating Collaborative Research

MRC Technology is the exclusive commercialisation catalyst for the UK Medical Research Council (MRC), working to translate cutting edge scientific discoveries into commercial products.

We strive to bridge the gap between innovative basic science and making medicine. By providing novel biology and chemical tools, we give pharmaceutical and biotechnology companies new starting points for drug discovery, based on MRC advances in science.

We commercialise our discoveries in order to benefit healthcare. Any income we generate goes back to MRC for further research.

Working with MRC can be beneficial to your company - you will have access to some of the world’s finest scientific minds and inventions. Indeed, our expertise is already used by many of the world’s leading pharmaceutical companies.

There are many ways of working with us and adding value to your company by accessing MRC know-how, for example: IP licensing opportunities, Antibody Humanization, Drug Discovery Initiatives and facilitating Collaborative Research. But whatever your company’s requirements, please do not hesitate to contact us – we’re happy to talk whatever your area of interest.

MRCT is delighted to welcome Dr Dave Tapolczay as its new CEO